PURPOSE:The objective of the present study was to analyze the physiological and metabolic changes occurring in rats subjected to high-fat diet for one month. METHODS:The animals received a modified AIN-93 diet with increased lipid content and decreased carbohydrate content, while the control group received the normal AIN-93 diet. RESULTS: It was observed that the high-fat diet did not induce weight gain but led to greater gain of hepatic fat compared to control. Biochemcal parameters, glycemia, total cholesterol and serum protein did not differ between groups. In parallel, rats receiving the high-fat diet consumed less feed. CONCLUSION: The development of obesity through high-fat diet is associated with increased energy intake and time of exposure to the diet, while the metabolic syndrome is more associated with the combination of a diet rich in fat and carbohydrates. Key words: Obesity. Lipids. Hyperphagia. Weight Gain. Rats. RESUMO OBJETIVO:Analisar modificações fisiológicas e metabólicas em ratos submetidos à dieta hiperlipídica por um mês. MÉTODOS: Os animais receberam a dieta AIN-93 modificada, com aumento do teor de lipídeos e diminuição do teor de carboidratos, enquanto o grupo controle recebeu a dieta AIN-93. RESULTADOS: Foi observado que a dieta hiperlipídica não induziu o ganho de peso, porém levou a um maior ganho de gordura hepática, em comparação ao grupo controle. Os parâmetros bioquímicos, glicemia, colesterol total e proteína sérica não diferiram entre os grupos. Ao mesmo tempo os ratos alimentados com dieta hiperlipídica, apresentaram uma menor ingestão de alimentos. CONCLUSÃO: O desenvolvimento da obesidade com a dieta hiperlipídica está associado com aumento da ingestão de energia e tempo de exposição à dieta, enquanto a síndrome metabólica está mais associada a dietas com alto teor de gordura e carboidratos, concomitantemente. Descritores: Obesidade. Lipídeos. Hiperfagia. Ganho de peso. Ratos. Picchi MG et al.

Our aim was to investigate and determine the associations between oxidative stress (OS), dyslipidemia and inflammation in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) using observational cross-sectional study. Twenty patients in CAPD and 48 in HD for at least 8 weeks and aged ≥18 years were included in the study. Individuals with malignant or acute inflammatory disease were excluded. A control group of 17 healthy individuals was also recruited. The biochemical parameter evaluations were analyzed using colorimetric kits for albumin, serum glucose, total cholesterol (TC) and lipid fractions. To determine the inflammatory status, CRP, IL-6 and TNF-α were analyzed by automated chemiluminescence kits. Plasma advanced oxidation protein products (AOPP) were determined by spectrophotometry. Mean AOPP levels were significantly higher for the HD group compared to the control, and there was no difference in AOPP concentrations between the control and CAPD groups. Dialysis patients had levels of inflammatory parameters higher than controls, and showed a high prevalence of patients with dyslipidemia, especially in CAPD. In the HD group, AOPP was positively correlated with triglycerides (TG) and inversely associated with HDL. Also the HD group was observed to have negative associations between TNF-α and HDL, LDL and TC. In the CAPD group, CRP was inversely correlated with HDL. Hemodialysis patients had increased protein OS and associations of inflammation and dyslipidemia were also observed in these dialysis groups. A more detailed characterization of the relations between oxidative stress and other more traditional risk factors has therapeutic importance, since cardiovascular diseases are the leading cause of death among dialysis patients.

No abstract

Peritoneal dialysis (PD) frequently leads to body weight gain, which appears to be a potential cause of the chronic inflammation frequently present in these patients. The consequences of this inflammation are impaired nutritional status, accelerated atherosclerosis, and increased mortality. To assess the association between inflammation and body fat in female patients treated with PD. Nineteen female patients on PD for at least 6 months with no infectious complications or malignant or acute inflammatory diseases. Nutritional status was determined by measuring weight, height, body mass index (BMI), waist (WC), and mid-arm circumferences (MAC), mid-arm muscle area, and tricipital fold (TCF). Bioelectrical impedance (BIA) was used to determine body composition. Biochemical evaluation included the determination of serum albumin, urea, creatinine, and C-reactive protein (CRP). The glucose absorbed from the dialysis solution was quantitated. According to BMI, two patients were classified as malnourished and ten as overweight/obese. Sixteen individuals had high WC measurements and 12 had excess body fat (BF) as measured by BIA. High CRP levels were observed in 12 patients, who had higher WC, MAC, BMI, TCF, and BF measurements compared to non-inflamed patients. Positive associations were detected between CRP and BMI, MAC, WC, and TCF. Associations between BF and CRP suggest that adiposity may be a potent exacerbating factor of inflammation in this population, especially visceral fat. Thus, obesity may be considered to be one more factor responsible for the early atherosclerosis and high cardiovascular mortality observed in these patients.

The dialysis modality adopted influences protein OS, but it has no effect on antioxidant status or inflammation. Hemodialysis probably exacerbates OS due to the increased bioincompatibility of the dialysis procedure, and this scenario seems to be related to the intravenous supplementation of vitamin C. Peritoneal dialysis allows for a better oxidative balance, which may reduce cardiovascular risk.

LBM, fat mass, ECF/TBW and Albumin losses (r¼0.61, po0.01).In conclusion, pre-dialysis s-Alb levels were affected by, not albumin losses to dialysate, but sex and CRP reflecting the inflammatory status.http://dx.The main cause of death among dialysis is cardiovascular. The development of atherosclerosis involves several classical risk factors such as diabetes mellitus, hypertension and dyslipidemia. Knowing their characteristics allows planning therapeutic actions aimed at reducing mortality. The aim was to characterize clinically a sample of HD patients. Forty-nine patients on HD for at least 6 months were included. Individuals with malignant disease, active inflammation, in use of omega-3 oil or anticoagulants were excluded. Clinical data were collected from medical records. Albumin, urea, creatinine, total cholesterol, triglycerides (TG), phosphorus and potassium were measured. The average age of patients (27 men and 22 women) was 49.9 7 14.3 years. The mean duration of the HD was 41.8 7 35.9 months. About 50% were diabetic and 100% were hypertensive. Dyslipidemia was observed in 47% of patients and 51% had hypoalbuminaemia. Hyperphosphatemia was found in 77.5% and hyperkalemia was observed in 43% of patients. Negative association between TG and urea was found (r ¼ -0.33, p ¼ 0.03). The patients treated for a longer time for HD showed higher levels of phosphate. It is evident the presence of metabolic imbalance in patients treated for HD. Therapeutic interventions such as supplementation with omega-3 fatty acids may be important in reducing morbidity and mortality in this population.